MeiraGTx Holdings plc MGTX
Updated: 9 Aug 2026
No signal published yet
We already track MeiraGTx Holdings and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow MeiraGTx Holdings plc? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow MeiraGTx Holdings free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
In July 2026, MeiraGTx entered into a strategic investment agreement with Oberland Capital for up to $400 million to support the development and commercialization of its gene therapy programs. The deal includes up to $375 million in non-dilutive capital in exchange for capped royalty payments and up to $25 million in equity investment.
What Firelda Watch includes for MeiraGTx Holdings plc
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow MeiraGTx Holdings plc? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow MeiraGTx Holdings free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more